The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Anti Peptic Ulcer Drugs-Global Market Insights and Sales Trends 2024

Anti Peptic Ulcer Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1830154

No of Pages : 108

Ask Your Query
Synopsis
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
The global Anti Peptic Ulcer Drugs market size is expected to reach US$ 21380 million by 2029, growing at a CAGR of 13.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anti Peptic Ulcer Drugs in various end use industries. The expanding demands from the Gastritis, Gastric Ulcers, Duodenal Ulcers and Gastroesophageal Reflux Disease (GERD), are propelling Anti Peptic Ulcer Drugs market. Proton Pump Inhibitors (PPIs), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Potassium-Competitive Acid Blockers (P-CAB) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti Peptic Ulcer Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti Peptic Ulcer Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti Peptic Ulcer Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti Peptic Ulcer Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti Peptic Ulcer Drugs covered in this report include Eisai, Daewoong Pharmaceutical, Takeda Pharmaceutical, HeliCure, AstraZeneca, Ore Holdings, Sihuan Pharmaceutical, GlaxoSmithKline and Pfizer, etc.
The global Anti Peptic Ulcer Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Holdings
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim
Global Anti Peptic Ulcer Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti Peptic Ulcer Drugs market, Segment by Type:
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs
Global Anti Peptic Ulcer Drugs market, by Application
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti Peptic Ulcer Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti Peptic Ulcer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Anti Peptic Ulcer Drugs Market Overview
1.1 Anti Peptic Ulcer Drugs Product Overview
1.2 Anti Peptic Ulcer Drugs Market Segment by Type
1.2.1 Proton Pump Inhibitors (PPIs)
1.2.2 Potassium-Competitive Acid Blockers (P-CAB)
1.2.3 Antacids
1.2.4 H2 Antagonists
1.2.5 Antibiotics
1.2.6 Ulcer Protective Drugs
1.3 Global Anti Peptic Ulcer Drugs Market Size by Type
1.3.1 Global Anti Peptic Ulcer Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Anti Peptic Ulcer Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti Peptic Ulcer Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti Peptic Ulcer Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti Peptic Ulcer Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti Peptic Ulcer Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti Peptic Ulcer Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti Peptic Ulcer Drugs Sales Breakdown by Type (2018-2023)
2 Global Anti Peptic Ulcer Drugs Market Competition by Company
2.1 Global Top Players by Anti Peptic Ulcer Drugs Sales (2018-2023)
2.2 Global Top Players by Anti Peptic Ulcer Drugs Revenue (2018-2023)
2.3 Global Top Players by Anti Peptic Ulcer Drugs Price (2018-2023)
2.4 Global Top Manufacturers Anti Peptic Ulcer Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti Peptic Ulcer Drugs Market Competitive Situation and Trends
2.5.1 Anti Peptic Ulcer Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti Peptic Ulcer Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti Peptic Ulcer Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti Peptic Ulcer Drugs Market
2.8 Key Manufacturers Anti Peptic Ulcer Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti Peptic Ulcer Drugs Status and Outlook by Region
3.1 Global Anti Peptic Ulcer Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti Peptic Ulcer Drugs Historic Market Size by Region
3.2.1 Global Anti Peptic Ulcer Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Anti Peptic Ulcer Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Anti Peptic Ulcer Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti Peptic Ulcer Drugs Forecasted Market Size by Region
3.3.1 Global Anti Peptic Ulcer Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Anti Peptic Ulcer Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Anti Peptic Ulcer Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti Peptic Ulcer Drugs by Application
4.1 Anti Peptic Ulcer Drugs Market Segment by Application
4.1.1 Gastritis
4.1.2 Gastric Ulcers
4.1.3 Duodenal Ulcers
4.1.4 Gastroesophageal Reflux Disease (GERD)
4.2 Global Anti Peptic Ulcer Drugs Market Size by Application
4.2.1 Global Anti Peptic Ulcer Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Anti Peptic Ulcer Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti Peptic Ulcer Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti Peptic Ulcer Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti Peptic Ulcer Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti Peptic Ulcer Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti Peptic Ulcer Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti Peptic Ulcer Drugs Sales Breakdown by Application (2018-2023)
5 North America Anti Peptic Ulcer Drugs by Country
5.1 North America Anti Peptic Ulcer Drugs Historic Market Size by Country
5.1.1 North America Anti Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti Peptic Ulcer Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Anti Peptic Ulcer Drugs Sales in Value by Country (2018-2023)
5.2 North America Anti Peptic Ulcer Drugs Forecasted Market Size by Country
5.2.1 North America Anti Peptic Ulcer Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Anti Peptic Ulcer Drugs Sales in Value by Country (2024-2029)
6 Europe Anti Peptic Ulcer Drugs by Country
6.1 Europe Anti Peptic Ulcer Drugs Historic Market Size by Country
6.1.1 Europe Anti Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti Peptic Ulcer Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti Peptic Ulcer Drugs Sales in Value by Country (2018-2023)
6.2 Europe Anti Peptic Ulcer Drugs Forecasted Market Size by Country
6.2.1 Europe Anti Peptic Ulcer Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti Peptic Ulcer Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti Peptic Ulcer Drugs by Region
7.1 Asia-Pacific Anti Peptic Ulcer Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti Peptic Ulcer Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti Peptic Ulcer Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti Peptic Ulcer Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti Peptic Ulcer Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti Peptic Ulcer Drugs Sales in Value by Region (2024-2029)
8 Latin America Anti Peptic Ulcer Drugs by Country
8.1 Latin America Anti Peptic Ulcer Drugs Historic Market Size by Country
8.1.1 Latin America Anti Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti Peptic Ulcer Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti Peptic Ulcer Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Anti Peptic Ulcer Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti Peptic Ulcer Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti Peptic Ulcer Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti Peptic Ulcer Drugs by Country
9.1 Middle East and Africa Anti Peptic Ulcer Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti Peptic Ulcer Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti Peptic Ulcer Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti Peptic Ulcer Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti Peptic Ulcer Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti Peptic Ulcer Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti Peptic Ulcer Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eisai
10.1.1 Eisai Company Information
10.1.2 Eisai Introduction and Business Overview
10.1.3 Eisai Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eisai Anti Peptic Ulcer Drugs Products Offered
10.1.5 Eisai Recent Development
10.2 Daewoong Pharmaceutical
10.2.1 Daewoong Pharmaceutical Company Information
10.2.2 Daewoong Pharmaceutical Introduction and Business Overview
10.2.3 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Products Offered
10.2.5 Daewoong Pharmaceutical Recent Development
10.3 Takeda Pharmaceutical
10.3.1 Takeda Pharmaceutical Company Information
10.3.2 Takeda Pharmaceutical Introduction and Business Overview
10.3.3 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Products Offered
10.3.5 Takeda Pharmaceutical Recent Development
10.4 HeliCure
10.4.1 HeliCure Company Information
10.4.2 HeliCure Introduction and Business Overview
10.4.3 HeliCure Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 HeliCure Anti Peptic Ulcer Drugs Products Offered
10.4.5 HeliCure Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Anti Peptic Ulcer Drugs Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Ore Holdings
10.6.1 Ore Holdings Company Information
10.6.2 Ore Holdings Introduction and Business Overview
10.6.3 Ore Holdings Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ore Holdings Anti Peptic Ulcer Drugs Products Offered
10.6.5 Ore Holdings Recent Development
10.7 Sihuan Pharmaceutical
10.7.1 Sihuan Pharmaceutical Company Information
10.7.2 Sihuan Pharmaceutical Introduction and Business Overview
10.7.3 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Products Offered
10.7.5 Sihuan Pharmaceutical Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GlaxoSmithKline Anti Peptic Ulcer Drugs Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 Pfizer
10.9.1 Pfizer Company Information
10.9.2 Pfizer Introduction and Business Overview
10.9.3 Pfizer Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Pfizer Anti Peptic Ulcer Drugs Products Offered
10.9.5 Pfizer Recent Development
10.10 Abbott Laboratories
10.10.1 Abbott Laboratories Company Information
10.10.2 Abbott Laboratories Introduction and Business Overview
10.10.3 Abbott Laboratories Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Abbott Laboratories Anti Peptic Ulcer Drugs Products Offered
10.10.5 Abbott Laboratories Recent Development
10.11 Yuhan Corporation
10.11.1 Yuhan Corporation Company Information
10.11.2 Yuhan Corporation Introduction and Business Overview
10.11.3 Yuhan Corporation Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Yuhan Corporation Anti Peptic Ulcer Drugs Products Offered
10.11.5 Yuhan Corporation Recent Development
10.12 Cadila Healthcare
10.12.1 Cadila Healthcare Company Information
10.12.2 Cadila Healthcare Introduction and Business Overview
10.12.3 Cadila Healthcare Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Cadila Healthcare Anti Peptic Ulcer Drugs Products Offered
10.12.5 Cadila Healthcare Recent Development
10.13 Boehringer Ingelheim
10.13.1 Boehringer Ingelheim Company Information
10.13.2 Boehringer Ingelheim Introduction and Business Overview
10.13.3 Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Boehringer Ingelheim Anti Peptic Ulcer Drugs Products Offered
10.13.5 Boehringer Ingelheim Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti Peptic Ulcer Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti Peptic Ulcer Drugs Industrial Chain Analysis
11.4 Anti Peptic Ulcer Drugs Market Dynamics
11.4.1 Anti Peptic Ulcer Drugs Industry Trends
11.4.2 Anti Peptic Ulcer Drugs Market Drivers
11.4.3 Anti Peptic Ulcer Drugs Market Challenges
11.4.4 Anti Peptic Ulcer Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti Peptic Ulcer Drugs Distributors
12.3 Anti Peptic Ulcer Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock